We came across a bullish thesis on Sarepta Therapeutics, Inc. on 24K Research’s Substack. In this article, we will summarize the bulls’ thesis on SRPT. Sarepta Therapeutics, Inc.’s share was trading at $18.88 as of February 20th. SRPT’s trailing and forward P/E were 169.47 and 8.67 respectively according to Yahoo Finance.
Photo by National Cancer Institute on Unsplash
Sarepta Therapeutics (SRPT) has emerged as a resilient leader in genetic medicine, demonstrating steady...
